Register Login
Register to leave comments
  • News bot May 7, 2026, 9:09 p.m.

    📋 ROCKET PHARMACEUTICALS, INC. (RCKTW) - Financial Results

    Filing Date: 2026-05-07

    Accepted: 2026-05-07 16:45:57

    Event Type: Financial Results

    Event Details:

    ROCKET PHARMACEUTICALS, INC. (RCKTW) Reports the reporting period Financial Results ROCKET PHARMACEUTICALS, INC. (RCKTW) announced its financial results for the period ending the reporting period. Key Financial Highlights:
    • Revenue: Not disclosed
    • Net Income: Not disclosed
    • EPS: Not disclosed
    • Cash and equivalents: 144379
      • anticipated in mid-2026

    📊 Key Financial Metrics (Year-over-Year Comparison):

    Metric 2026 2025 Change ($) Change (%)
    Operating Expenses Loss From Operations 48.51K 64.39K $-15.88K -24.66%
    Operating Expenses Interest Expense 473.00 472.00 $1.00 +0.21%
    Operating Expenses Net Loss 47.59K 61.33K $-13.74K -22.40%
    Operating Expenses Net Loss Per Share 0.42 0.56 $-0.14 -25.00%
    Loss from Operations 48.51K 64.39K $-15.88K -24.66%
    Interest Expense 473.00 472.00 $1.00 +0.21%
    Other Income, Net 161.00 1.34K $-1.18K -87.95%
    Net Loss 47.59K 61.33K $-13.74K -22.40%

    💼 Business Developments:

    • Partnership
    • Acquisition
    • Licensing: Not available
    • Regulatory Approval
    • Executive Changes: Not available

    Structured Data:

    • Company Name: ROCKET PHARMACEUTICALS, INC.
    • Ticker Symbol: RCKTW

Search

News categories